Pacer Advisors, Inc. Astrazeneca PLC Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Pacer Advisors, Inc. holds 54,944 shares of AZN stock, worth $3.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,944

Previous 55,050 0.19%

Holding current value

$3.67 Million

Previous $4.29 Million 0.28%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $8,127 - $9,287	-106 Reduced 0.19%	54,944 $4.28 Million
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $14,430 - $17,459	-216 Reduced 0.39%	55,050 $4.29 Million
Q1 2024 May 10, 2024	SELL	$61.03 - $69.57 $31,003 - $35,341	-508 Reduced 0.91%	55,266 $3.74 Million
Q4 2023 Jan 16, 2024	BUY	$61.89 - $69.28 $200,894 - $224,882	3,246 Added 6.18%	55,774 $3.76 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $532,742 - $589,015	8,215 Added 18.54%	52,528 $3.56 Million
Q2 2023 Jul 12, 2023	SELL	$69.91 - $75.81 $978,530 - $1.06 Million	-13,997 Reduced 24.0%	44,313 $3.17 Million
Q1 2023 May 02, 2023	BUY	$63.15 - $71.6 $1.12 Million - $1.27 Million	17,753 Added 43.77%	58,310 $4.05 Million
Q4 2022 Feb 06, 2023	BUY	$54.21 - $70.44 $1.27 Million - $1.65 Million	23,405 Added 136.46%	40,557 $2.75 Million
Q3 2022 Oct 18, 2022	BUY	$53.02 - $135.75 $23,752 - $60,816	448 Added 2.68%	17,152 $941,000
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $989,879 - $1.19 Million	16,704 New	16,704 $1.1 Million
Q1 2022 Apr 05, 2022	SELL	$55.72 - $67.12 $1.31 Million - $1.58 Million	-23,498 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$54.02 - $63.83 $15,719 - $18,574	-291 Reduced 1.22%	23,498 $1.37 Million
Q3 2021 Oct 15, 2021	BUY	$55.56 - $60.79 $180,570 - $197,567	3,250 Added 15.82%	23,789 $1.43 Million
Q2 2021 Jul 21, 2021	BUY	$48.42 - $60.18 $29,052 - $36,108	600 Added 3.01%	20,539 $1.23 Million
Q1 2021 Apr 05, 2021	SELL	$47.16 - $54.44 $81,728 - $94,344	-1,733 Reduced 8.0%	19,939 $991,000
Q4 2020 Jan 20, 2021	SELL	$48.52 - $58.02 $234,836 - $280,816	-4,840 Reduced 18.26%	21,672 $1.08 Million
Q3 2020 Oct 19, 2020	BUY	$53.07 - $61.1 $1.41 Million - $1.62 Million	26,512 New	26,512 $1.45 Million
Q1 2020 Apr 23, 2020	SELL	$37.79 - $51.33 $753,910 - $1.02 Million	-19,950 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$42.46 - $50.46 $250,598 - $297,814	5,902 Added 42.01%	19,950 $995,000
Q3 2019 Oct 10, 2019	BUY	$40.12 - $45.47 $208,142 - $235,898	5,188 Added 58.56%	14,048 $626,000
Q2 2019 Aug 12, 2019	BUY	$37.28 - $41.68 $330,300 - $369,284	8,860 New	8,860 $366,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $207B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Astrazeneca PLC Transaction History